Omega-3 Fatty Acids in Brain and Neurological Health

Omega-3 Fatty Acids in Brain and Neurological Health

von: Ronald Ross Watson, Fabien De Meester

Elsevier Reference Monographs, 2014

ISBN: 9780124105478 , 496 Seiten

Format: PDF, ePUB

Kopierschutz: DRM

Windows PC,Mac OSX für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Apple iPod touch, iPhone und Android Smartphones

Preis: 155,00 EUR

Mehr zum Inhalt

Omega-3 Fatty Acids in Brain and Neurological Health


 

Front Cover

1

Omega-3 Fatty Acids in Brain and Neurological Health

4

Copyright Page

5

Contents

6

Preface

12

List of Contributors

14

Acknowledgments

18

1 Enhanced Longevity and Role of Omega-3 Fatty Acids

20

Introduction

20

Longevity

20

Food Restriction for Enhanced Longevity

21

Calorie Restriction for Longevity

21

Smoking and Reduced Longevity

21

Genetics, a Key Modifier of Longevity

22

Genetic Diseases and Longevity

22

Genomics

23

Environmental Factors and Longevity

23

Animal Tests and Longevity

24

Omega-3 Fatty Acids and Longevity

24

References

25

Further Reading

26

2 Molecular Gerontology: Principles and Perspectives for Interventions

28

Introduction

28

Homeostasis Versus Homeodynamics

28

Molecular Basis of Aging

29

Free Radical Theory of Aging

29

Protein Error Theory of Aging

30

From FRTA and PETA to Higher Order Theories

30

Genetics, Post-Genetics, and Epigenetics of Aging

30

Epigenetics of Aging

31

Aging Interventions

31

Gene Therapy

31

Manipulating the Milieu

33

Hormetics, Hormesis, and Hormetins

33

References

34

3 Peroxisomal Pathways, their Role in Neurodegenerative Disorders and Therapeutic Strategies

38

Peroxisomes

38

Ether Lipid Synthesis

38

a-oxidation

39

ß-oxidation

39

Peroxisomal Pathologies

42

Leukodystrophies

43

X-linked Adrenoleukodystrophy

43

Lipid and Steroid Hormone Modifications

44

Biological Markers of X-ALD

44

Therapeutic Strategies

44

Fatty Acids and Dietary Intervention

45

Hormone Replacement Therapy

46

Gene Therapy

46

Demyelination and Other Leukodystrophies

46

Conclusion

47

References

47

4 Unregulated Lipid Peroxidation in Neurological Dysfunction

50

Introduction

50

Lipid Oxidation Biomarkers for Neurological Dysfunction

51

Lipid Peroxidation Products from Linoleic Acid

51

Lipid Peroxidation Products from AA

51

Hydroxyeicosatetraenoic Acids

51

F2-Isoprostanes

52

Isofurans

52

Lipid Peroxidation Products from Docosahexaenoic Acid

53

Neuroprostanes

53

Neurofurans

53

Lipid Peroxidation-Derived Short-Chain Aldehydes

53

Lipid Peroxidation Products from Cholesterol

54

Neurological Dysfunction Associated with Lipid Peroxidation

56

Mechanisms of Free Radical Production in Neurological Disorders

57

Alzheimer’s Disease

57

Parkinson’s Disease

57

Amyotrophic Lateral Sclerosis

60

Stroke

61

Down Syndrome

61

Other Neurological Dysfunctions in Childhood

62

Therapeutic Intervention with Antioxidants for Neurological Dysfunction

62

References

63

Additional References

70

5 Obesity, Western Diet Intake, and Cognitive Impairment

76

Obesity and Cognitive Impairment

76

Western Diet Intake and Cognitive Impairment

77

Western Diet Intake and Cognitive Impairment: Underlying Neuroendocrine Mechanisms

78

Summary

80

References

80

6 Genetic Risk Factors for Diabetic Neuropathy

82

Diabetes Mellitus and Its Complications

82

Diabetic Neuropathy: General Characteristics

82

Risk Factors for Diabetic Neuropathy and pathophysiological Mechanisms

82

Genetic Risk Factors for Diabetic Neuropathy

83

Potential Use of Genetic Risk Factors in Clinical Practice

85

References

86

7 n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and Neuroinflammation

88

Overview

88

DHA in the Brain

89

EPA-Derived Lipid Mediators in the Brain

90

DHA-derived Lipid Mediators in the Brain

92

DHA-derived D-series Resolvins

92

DHA-derived Protectins and Neuroprotectins

92

Effect of EPA and DHA in Neurological Disorders

95

Conclusion

97

References

97

8 The Impact of Omega-3 Fatty Acids on Quality of Life

100

Introduction

100

Assessment of QoL

100

Current Evidence on Omega-3 Fatty Acids and QoL

101

Evidence from Observational Studies

101

Evidence from Clinical Trials

102

Discussion

102

Conclusion and Recommendations

103

References

103

9 Mammalian Fatty Acid Amides of the Brain and CNS

106

Introduction

106

Primary Fatty Acid Amides

106

N-Acylethanolamines (NAEs)

109

N-Acyl Amino Acids (NAAs)

112

NAGs, a Specific Class of the NAAs

113

N-Acyl Taurines, a Specific Class of the NAAs

116

Other N-Acyl Amino Acids

117

N-Acyldopamines

118

The Relevance of the Fatty Acid Amides to Neurological Disease

118

Acknowledgements

121

References

121

10 Low Omega-3 Fatty Acids Diet and the Impact on the Development of Visual Connections and Critical Periods of Plasticity

128

Introduction

128

Nutrition and the Impact of Omega-3 Fatty Acids on Brain Development

128

The Development of Visual Topographical Maps

131

Critical Periods for Brain Development

132

Role of Omega-3 on Development of Central Visual Connections

133

References

136

11 The Effects of Omega-3 Polyunsaturated Fatty Acids on Maternal and Child Mental Health

140

Introduction

140

The Role of Omega-3 Fatty Acids in Neurotransmission

140

DHA and Maternal Mental Health

141

Postpartum Depression

141

Omega-3 Fatty Acids in Postpartum Depression

142

Omega-3 Fatty Acids and Child Mental Health

142

Neurodevelopmental Outcomes: Infancy through Childhood

142

Infancy

142

Childhood

143

Childhood Developmental Disorders

143

Attention Deficit Hyperactivity Disorder

144

Childhood Depression

144

Autistic Spectrum Disorders

145

Conclusion

145

References

146

12 Pain as Modified by Polyunsaturated Fatty Acids

150

Introduction

150

Factors Involved in the Supply and Physiological Function of Fatty Acids in the Brain

151

Blood–Brain Barrier

151

Fatty Acid Transporter Protein

152

Fatty Acid Binding Protein

152

Long-Chain Fatty Acid Receptor GPR40

153

Toll Like Receptor 4

153

Involvement of Lipids, Fatty Acids, and Their Metabolites in Pain Regulation

153

Dietary Lipids

153

Omega-3 Fatty Acids

154

DHA

154

Metabolites Derived from Omega-3 Fatty Acids

155

Omega-6 Fatty Acids and Their Metabolites

157

Prostaglandins

157

Leukotrienes

159

Platelet-Activating Factor

159

Lysophosphatidic Acid

160

Future Prospects

160

References

161

13 Fish Oil Supplementation Prevents Age-Related Memory Decline: Involvement of Nuclear Hormone Receptors

166

Introduction

166

Effects of Aging on Incorporation of Docosahexaenoic Acid in Brain Phospholipids

166

Effects of Aging on DHA Biosynthesis

167

DHA is Involved in Learning and Memory

168

Dietary Fish Oil and Prevention of Age-Related Memory Decline

169

Animal Studies

169

Human Studies

171

DHA Improves Synaptic Plasticity During Aging: Involvement of Retinoid X Receptors and Peroxisome Proliferator-Activated Re...

172

Summary and Concluding Remarks

174

References

176

14 Role of Omega-3 Fatty Acids in Brain and Neurological Health with Special Reference to Clinical Depression

182

Introduction

182

Omega-3 Fatty Acids

182

Factors that Interfere with Conversion of ALA

183

Omega-3 to Omega-6 Ratio

183

Genetic Factors

184

Dietary and Lifestyle Factors

184

Saturated fat – trans-fat

184

Caffeine, Nicotine, Alcohol, Sugar

184

Stress

184

Co-nutrients

184

Status of Omega-3 Fatty Acids in Clinical Depression

184

Nutrient Co-Factor Deficiencies

185

Zinc Deficiency

185

Selenium Deficiency

185

Folic Acid Deficiency

185

Antioxidants

185

Vitamin B6, Tryptophan, and Serotonin

186

Omega-3 Fatty Acids

186

Neurological Alterations in Depression

186

Possible Mechanisms for Links Between Omega-3 Fatty Acids and Depression

188

Omega-3 Fatty Acids Affect Cell Membrane Integrity and Fluidity

188

Omega-3 Fatty Acids Decrease the Production of Pro-Inflammatory Cytokines

189

Omega-3 Fatty Acids and Hippocampal Neurogenesis

189

Impact of Diet on AHN

189

Clinical Trials Supporting the Role of Omega-3 Fatty Acids in MDD

190

Conversion of ALA to EPA and DHA from Flax Seed Oil

192

Probable Mode of Action of Flax Seed Oil in Depression

192

Conclusion

194

References

195

Further Reading

198

15 Omega-3 Fatty Acid Supplementation for Major Depression with Chronic Disease

200

Introduction

200

Omega-3 Fatty Acids

200

Major Depressive Disorder

201

Omega-3 Fatty Acids and Depression

201

Effects of Omega-3 Fatty Acids on Depression with Cardiovascular Disorders

202

Effects of Omega-3 Fatty Acids on Depression with Diabetes

202

Effects of Omega-3 Fatty Acids on Depression and Pregnancy

203

Effects of Omega-3 Fatty Acids on Depression and Old Age

203

Effect of Omega-3 Fatty Acids on Anxiety and Depression in Students

203

Summary

204

References

204

16 The Effectiveness of Fish Oil as a Treatment for ADHD

206

A review of the Literature

206

Purpose

207

Analyzing the Studies

207

Findings

207

The Effect of Fish Oil on the Behavioral/Physical Symptoms of ADHD

209

Omega 3

209

Omega-3 and Omega-6

210

Combination of Essential Fatty Acids and other Supplements

211

Fatty Acid Levels in Blood of Patients with ADHD

212

Omega 3

212

No Supplements were Given

212

Conclusion

212

Final Thought

217

References

217

Further Reading

218

17 Fatty Acids and the Aging Brain

220

Introduction

220

Physiologic Brain Aging

221

Structural Changes

221

Macro-Structural Changes

221

Micro-Structural Changes

222

Chemical Changes

222

Dopamine

222

Serotonin

222

Glutamate

223

Cognitive Changes

223

Changes in Attention

223

Changes in Memory

223

Changes in Orientation

224

Changes in Perception

224

Changes in Executive Control

224

Fatty Acids and Brain Aging

224

Fatty Acid Basics: An Introduction to the Biochemistry of Fatty Acids

224

Fatty Acid Composition of the Brain

225

Omega Fatty Acids

225

Function of Omega-3 Fatty Acids in the Brain

225

Neural Mechanisms

225

Neurogenesis

225

Neurotransmission

226

Reduction of Amyloid-ß Production

226

Increasing Brain-Derived Neurotrophic Factor

226

Vascular Mechanisms

226

Reduction of Inflammation

226

Lowering of Thrombosis

226

Blood Pressure Reduction

227

Lowering Triglyceride Levels

227

Sources of Omega Fatty Acids

227

Omega Fatty Acid Metabolism

227

Pathological Brain Aging

228

Alzheimer’s Disease

228

Disease Characteristics

228

Structural Differences from Normal Aging

228

Chemical Differences

229

Cognitive Differences

229

Disease Mechanisms

229

Vascular Dementia

230

Disease Characteristics

230

Structural Changes

230

Cognitive Changes

230

Chemical Changes

230

Disease Mechanisms

230

Mixed Dementia

230

Protective Effect of Omega-3 Fatty Acids against Dementia

231

Conclusion

232

References

232

Further Reading

238

18 Cerebrovascular Changes: The Role of Fat and Obesity

240

Introduction

240

Vascularization of the Brain

240

The Blood–Brain Barrier

241

Effects of a High Fat Diet and Obesity on Overall Health and Proposed Mechanisms

241

Clinical Studies: Vascular Changes Due to a High Fat Diet and Obesity

242

Animal Studies: Vascular Changes Due to a High Fat Diet and Obesity

243

Impact of Omega-3 Fatty Acids on Vascular Health

245

Conclusion

245

References

246

19 Effects of Omega-3 Fatty Acids on Alzheimer’s Disease

250

Introduction

250

Omega-3 Fatty Acids Biology in Health

250

Alzheimer’s Disease

250

Omega-3 Fatty Acid: a Role in Alzheimer’s Disease?

251

DHA Deficiency and Neurological Function Affected by Diabetes in Alzheimer’s Disease

251

Animal Models, Diabetes, and Alzheimer’s Disease

252

Omega-3 Fatty Acids in Prevention and Treatment of Alzheimer’s Disease

253

References

254

20 Substantia Nigra Modulation by Essential Fatty Acids

256

Importance of Essential Fatty Acids as Neuroprotectors During Brain Development and Aging

256

Substantia Nigra Vulnerability to Neurodegeneration

257

Substantia Nigra Dopamine Cell Populations Display Differential Vulnerability to Lesions

258

Repercussion of EFA Deficiency or Supplementation on Midbrain Dopaminergic Systems

259

Potential Mechanisms Involved in Substantia Nigra Dopamine Cell Loss Induced by EFA Dietary Restriction

260

Acknowledgments

264

References

264

Further Reading

268

21 The Role of Omega-3 Fatty Acids in Hippocampal Neurogenesis

270

Introduction

270

Adult Neurogenesis

271

Measurement of Neurogenesis (Markers of Proliferation)

271

Omega-3 PUFAs and Hippocampal Neurogenesis

272

Developmental Neurogenesis

272

Adult Hippocampal Neurogenesis

273

Mechanisms of Action

273

References

278

22 Imaging Brain DHA Metabolism in Vivo, in Animals, and Humans

284

Introduction

284

Quantitative Imaging of Brain DHA Metabolism in Rodents

284

Incorporation of Circulating PUFAs into Brain Membrane Lipids

284

Methods and models for determining PUFA incorporation into brain

286

Imaging Membrane Synthesis

287

Neuroplasticity with Ocular Enucleation

287

Brain Tumor Imaging

287

Upregulated DHA and AA Releasing Enzymes in an Animal Model of the Metabolic Syndrome

288

Neurotransmission

288

Human Mutations and Mouse Knockouts of iPLA2ß

289

Quantitative Imaging of Brain DHA Metabolism in Human Subjects

290

Baseline Brain DHA Incorporation

290

Upregulated Incorporation Coefficients in Chronic Alcoholics

290

Summary and Conclusions

291

Acknowledgments

292

References

292

23 Obesity and Migraine in Children

296

Introduction

296

Epidemiological Relationship Between Migraine and Obesity

296

Comorbidity

297

Cognitive Profile, Migraine, and Obesity

298

Proposed Mechanism for the Relationship Between Obesity and Migraine

298

Lifestyle Factors

299

Influence of Weight Loss on Chronic Headache in Obese People and Effects of the Preventive Treatment of Migraine on Weight ...

300

Conclusions

302

References

302

24 Dietary Omega-3 Sources during Pregnancy and the Developing Brain: Lessons from Studies in Rats

306

Introduction

306

ALA Supplementation and Brain Fatty Acid Composition

307

Long-chain Omega-3 PUFA Supplementation and Brain Fatty Acid Composition

310

Direct Comparison of ALA and Long-chain Omega-3 PUFA Supplementation on Brain Fatty Acid Composition

316

Conclusions

316

References

320

25 Omega-3 Fatty Acids and Cognitive Behavior

322

Introduction

322

Infants and Children

322

Maternal Supplementation

323

Supplementation During Infancy

326

Supplementation During Childhood

328

Young Adults

330

Older Adults

333

Epidemiological Studies: The Association Between Omega-3 PUFA Intake, Omega-3 PUFA Levels, and Cognitive Decline

333

RCTs: Healthy Older Adults

338

RCTs: Older Adults with Mild Cognitive Impairment or Alzheimer’s Disease

338

Conclusion

341

References

341

26 Lipids and Lipid Signaling in Drosophila Models of Neurodegenerative Diseases

346

Introduction

346

Drosophila as a Model System of Neurodegenerative Diseases

346

Genetic Tools for Making Neurodegenerative Disease Models in Drosophila

346

P-Element-Mediated Mutagenesis

346

UAS-GAL4-Based Gene Expression System

347

Reporters for Amyloid Precursor Protein .-secretase Activity in Drosophila

348

Representative Drosophila Models for Neurodegenerative Diseases

348

Effects of Lipids and Lipid Signaling on Drosophila Models of Neurodegenerative Diseases

349

Effects of PUFA and Cholesterol Levels on Drosophila AD Models Expressing Human Aß42

349

Effect of Phosphatidylethanolamine Depletion on .-secretase-Mediated APP Processing in Transgenic Drosophila

351

Effects of Lipid Signaling Enzyme Diacylglycerol Kinase e Inhibition on Mutant Huntingtin Toxicity

351

Drosophila Mutant of Very Long-Chain Acyl Coenzyme a Synthetase and Glyceryl Trioleate Oil

351

Lipids, TRP Channels, and Neurodegeneration in Drosophila

352

Points to Consider When Drosophila Models are Used for Studying the Role of Lipids

353

Perspective

353

References

354

27 Polyunsaturated Fatty Acids in Relation to Sleep Quality and Depression in Obstructive Sleep Apnea Hypopnea Syndrome

356

Introduction

356

OSAHS

356

Sleepiness

357

OSAHS and Associated Complications

357

Polyunsaturated Fatty Acids

357

PUFAs and Health

358

Depression

359

Link Between PUFAs and Depression in OSAHS

359

Sleep Quality

361

Link Between PUFAs and Sleep Quality in OSAHS

361

Conclusion

364

References

364

Further Reading

366

28 Omega-3 Fatty Acids in Intellectual Disability, Schizophrenia, Depression, Autism, and Attention-Deficit Hyperactivity D...

368

Introduction

368

Background

368

Plasma Lipids in Adults with Intellectual Disability and the Efficacy of Omega-3 Fatty Acids

369

Adrenoleukodystrophy and Adrenomyeloneuropathy

369

Fatty Acid, Lipid, and Cholesterol Levels

370

Plasma Lipids in Schizophrenia and the Efficacy of Omega-3 Fatty Acids

371

Plasma Lipids in Depressive Illness and Efficacy of Omega-3 Fatty Acids

372

Plasma Lipids in Autism and Efficacy of Omega-3 Fatty Acids

373

Plasma Lipids in ADHD and Efficacy of Omega-3 Fatty Acids

374

Conclusions

374

References

375

29 Effect of Omega-3 Fatty Acids on Aggression

378

Introduction

378

First Trial of Omega-3 PUFAs and Aggression in Young Adults

378

Effect of Omega-3 PUFAs on Aggression in Schoolchildren

379

Effect of Omega-3 PUFAs on Aggression in the Elderly

379

Effect of Omega-3 PUFAs on Aggression in Prisoners

380

Effect of Omega-3 PUFAs on Aggression in Patients with ADHD

380

Association Between Omega-3 PUFAs and Hostility in Patients with Schizophrenia

380

Mechanism of Action of Omega-3 PUFAs

380

Serotonin

380

Noradrenalin

381

Cortical-Hippocampal-Amygdala Pathway

381

Endocannabinoids

381

Brain-Derived Neurotrophic Factor

381

Conclusion

381

References

383

30 Multiple Sclerosis: Modification by Fish Oil

386

Introduction

386

Overview

386

Cellular Level of Multiple Sclerosis

387

Omega-3 Supplementation of MS Patients

388

Varying Results Amongst Researchers

388

Summary

389

Acknowledgement

390

References

390

31 Deuterium Protection of Polyunsaturated Fatty Acids against Lipid Peroxidation: A Novel Approach to Mitigating Mitochond...

392

Introduction

392

PUFAs in Mitochondrial Membranes and Oxidative Stress

392

Mitochondrial Dysfunction, Oxidative Stress, and PD

394

Isotope Protection of PUFAS Against autoxidation

395

Yeast Models Confirm the Non-Linear Protective Effect of D-PUFAs in vivo

397

Isotope Reinforcement of PUFA in Pre-Clinical PD Modeling

397

Pre-Clinical Efficacy

399

Conclusion

399

References

400

32 Obesity, Cognitive Functioning, and Dementia: A Lifespan Prospective

404

Introduction

404

Weight-Related Variables and Dementia

404

Prospective Studies with a Focus on Dementia

406

Prospective Studies Focusing on Cognitive Functioning

407

Weight and Cognitive Function: Role of CVD Factors

408

Interactions of Obesity and CVD Risk Factors

409

Controls and Potential Mediators

409

Initial Summary

410

MetS

410

Mechanisms: General

411

Early Influences on Relations between Obesity and Cognition

412

Morbid Obesity and Clinically Important Cognitive Deficit

413

Treatment of Overweight and Obesity

414

Treatment of Obesity with Omega-3 Fatty Acids

415

Omega-3 Fatty Acid Mechanisms for Reducing Weight Loss

416

Methodologies: General Issues

416

Measurement of Cognitive Function

416

Diagnosis of Dementia

417

Formal Definitions of Mild Cognitive Impairment

417

Prospective Designs

417

Neuroimaging Studies

417

Trials

417

Final Summary and Conclusions

417

References

418

33 Dairy Products and Cognitive Functions

422

Introduction

422

Review of the Literature

422

Early Cross-Sectional and Prospective Research Findings in Associations between Dairy and Cognition

424

Cross-Sectional Studies

424

Prospective Studies

424

Summary of These Study Findings

424

Focused Dairy–Cognition Studies

428

Cross-Sectional Studies

428

Randomized Controlled Trials

429

Discussion

429

Limitations of this Literature

429

Assessment of Cognitive Functioning

430

Control of Confounding Variables

430

Dietary Assessment

430

Mechanisms of Action

430

Epidemiological and Clinical Significance

431

Summary

432

Directions for Future Research

432

References

432

34 Obesity and Chronic Low Back Pain: A Kinematic Approach

436

Introduction

436

Quantitative Movement Analysis

437

Equipment

437

Obesity and LBP: Our Experience

438

Gait Analysis

438

Trunk Movement

440

Quantification of Functional Limitation

440

Quantification of the Effects of Osteopathic Manipulative Treatment

443

Conclusions

444

References

444

Further Reading

446

35 Fatty Acids and the Hippocampus

448

Introduction

448

Fatty Acids and Memory/Hippocampus

448

SFAs, Memory, and the Hippocampus – Evidence from Animal Models

448

Neurological Impact of Saturated Fat Consumption

449

BDNF

449

Oxidative Stress

449

Neuroinflammation

450

SFAs, Memory, and the Hippocampus – Human Data

450

Omega-3 Fatty Acids, Memory, and the Hippocampus – Evidence from Animal Studies

451

Can Omega-3 Fatty Acids Remediate Damage to the Hippocampus in Humans?

452

Omega-3 Fatty Acids and Depression

452

Omega-3 Fatty Acids and their Effect on Memory and Cognition

453

Conclusion on Human Data

453

General Conclusion: Fatty Acids and their Impact on the Hippocampus

454

Fatty Acids and AD

454

SFAs and Risk of AD

454

Putative Causal Basis for Link between SFAs and AD

454

Omega-3 Fatty Acids, Cognitive Decline, and Dementia

455

Global Prevalence

455

Matched Group Studies

455

Longitudinal Studies of Cognitive Decline

456

Cognitive Decline and Self-Report Measures of Dietary Intake

456

Dementia Diagnosis and Self-Report Measures of Dietary Intake

456

Cognitive Decline and Plasma Lipid Estimates

457

Dementia Diagnosis and Plasma Lipid Estimates

457

Prevention and Treatment Studies

457

Human Data – Conclusions

458

Omega-3 Fatty Acids, AD, and Memory Impairment – Evidence from Animal Models

458

General Discussion

459

References

460

Further Reading

464

36 Fish Oil Supplements, Contaminants, and Excessive Doses

466

Introduction

466

Mercury

466

Lead

468

Selenium

468

Arsenic

469

Cadmium

470

PCBs

470

Dichlorodiphenyltrichloroethane

471

Dieldrin

471

Conclusion

472

Acknowledgment

472

References

472

37 Introduction to Fish Oil Oxidation, Oxidation Prevention, and Oxidation Correction

474

Introduction

474

Oxidation Process

474

Oxidation Indicators

474

Prevention of Oxidation and Oxidative Stability

476

Oxidation Correction

477

Summary

478

References

478

Further Reading

479

Index

480